We are live on ! Find out more
BIIB icon

Biogen
BIIB

818 hedge funds and large institutions have $71B invested in Biogen in 2014 Q3 according to their latest regulatory filings, with 91 funds opening new positions, 312 increasing their positions, 278 reducing their positions, and 47 closing their positions.

New
Increased
Maintained
Reduced
Closed

94% more first-time investments, than exits

New positions opened: 91 | Existing positions closed: 47

14% more funds holding in top 10

Funds holding in top 10: 36 → 41 (+5)

12% more repeat investments, than reductions

Existing positions increased: 312 | Existing positions reduced: 278

5% more funds holding

Funds holding: 782 → 818 (+36)

4% more capital invested

Capital invested by funds: $68.4B → $71B (+$2.54B)

39% less call options, than puts

Call options by funds: $754M | Put options by funds: $1.23B

Holders
818
Holders Change
+36
Holders Change %
+4.6%
% of All Funds
23.73%
Holding in Top 10
41
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+13.89%
% of All Funds
1.19%
New
91
Increased
312
Reduced
278
Closed
47
Calls
$754M
Puts
$1.23B
Net Calls
-$479M
Net Calls Change
-$208M

Top Buyers

Rank Fund Capital Flow
1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$197M
2
Winslow Capital Management
Winslow Capital Management
Minnesota
+$148M
3
WBC
Westpac Banking Corp
Australia
+$139M
4
Capital World Investors
Capital World Investors
California
+$122M
5
Millennium Management
Millennium Management
New York
+$116M

Top Sellers

Rank Fund Capital Flow
1
Capital Research Global Investors
Capital Research Global Investors
California
-$904M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$706M
3
Norges Bank
Norges Bank
Norway
-$549M
4
Jennison Associates
Jennison Associates
New York
-$156M
5
BA
BlackRock Advisors
Delaware
-$90.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
TCM
851
Tran Capital Management
California
– -$315K -1,000 Closed
AF
852
Aldebaran Financial
– -$290K -920 Closed
BCM
853
BTR Capital Management
California
– -$290K -920 Closed
QC
854
QCM Cayman
Texas
– -$270K -857 Closed
EP
855
Edgestream Partners
New Jersey
– -$268K -849 Closed
ECM
856
ETrade Capital Management
Virginia
– -$205K -650 Closed
HAI
857
Hennessy Advisors Inc
California
– -$200K -635 Closed
NIM
858
NuWave Investment Management
New Jersey
– -$63K -199 Closed
FANJ
859
Financial Architects (New Jersey)
New Jersey
– -$48K -152 Closed
HHMI
860
Howard Hughes Medical Institute
Maryland
– -$45K -143 Closed
RFS
861
Rockefeller Financial Services
New York
– -$20K -65 Closed
TWM
862
Torch Wealth Management
Ohio
– -$16K -50 Closed
VAM
863
Visionary Asset Management
Texas
– -$10K -33 Closed
GC
864
Globeflex Capital
California
– -$3K -12 Closed
PAS
865
Partnervest Advisory Services
California
– -$1K -3 Closed
31 32 33 34
35

BIIB Hedge Fund Activity: Q3 2014 in Review

818 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Biogen (BIIB) for Q3 2014, worth a combined $71B — up 3.7% from $68.4B a quarter earlier.

Buyers outnumbered sellers: 91 funds opened new BIIB positions and 47 closed out — a net gain of 44 holders — while 312 added to existing stakes and 278 trimmed.

The largest buyer was T. Rowe Price Associates, adding an estimated $197M. The largest seller was Capital Research Global Investors, cutting an estimated $904M.

  • 818 institutional investors held Biogen (BIIB) as of Q3 2014, up from 782 in Q2 2014.
  • Funds reported $71B of Biogen stock for Q3 2014, up 3.7% quarter-over-quarter.
  • 91 funds opened new Biogen positions in Q3 2014 and 47 closed out, a net change of +44 holders.
  • The largest Biogen buyer in Q3 2014 was T. Rowe Price Associates, an estimated $197M added.
  • The largest Biogen seller in Q3 2014 was Capital Research Global Investors, an estimated $904M sold.

Based on aggregated 13F filings for Q3 2014.